FDA Orange Book

Is there a generic for Tivicay?

Tivicay contains dolutegravir. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Tivicay (dolutegravir). The Orange Book shows its last listed patent expires June 8, 2030.

Run it in Rivvi

Map Tivicay and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Tivicay products in the Orange Book

Tivicay products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oralEQ 10MG BASEDiscontinuedNone0None
tablet, oralEQ 25MG BASEDiscontinuedNone0None
tablet, oralEQ 50MG BASEMarketed (Rx)None0None

NDA 204790, held by VIIV HEALTHCARE CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Tivicay patents

Patents listed for Tivicay
PatentExpiresCoversUse codeNDA
8129385October 5, 2027Drug substance, Drug productNone204790
8129385*PEDApril 5, 2028Method of useNone204790
9242986December 8, 2029Drug substance, Drug productNone204790
9242986*PEDJune 8, 2030Method of useNone204790

Tivicay NDC codes

Questions

Is there a generic for Tivicay?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Tivicay (dolutegravir). The Orange Book shows its last listed patent expires June 8, 2030.

What is the generic name for Tivicay?

The active ingredient in Tivicay is dolutegravir, per the FDA Orange Book.

When does the Tivicay patent expire?

The last patent listed for Tivicay in the Orange Book expires June 8, 2030. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Tivicay and Dolutegravir

Try it on your own data today.

Free to start. Most teams are using it the same day.